News

Obesity drug maker Novo Nordisk's CEO to step down amid market struggle
Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down following a plunge in the company's share price ...
Novo Nordisk Stock Falls on Surprise CEO Departure
U.S.-listed shares of Novo Nordisk declined in premarket trading Friday on the surprise news that CEO Lars Fruergaard ...
Fierce Pharma39m
Novo to part ways with longtime CEO Lars Fruergaard Jørgensen, citing weight of market pressures
It’s the end of an era at Novo Nordisk as longtime CEO Lars Fruergaard Jørgensen—who recently shepherded the company through ...
Novo Nordisk CEO steps down in surprise move as 'market challenges' weigh on obesity drugmaker
"Considering the recent market challenges, the share price decline, and the wish from the Novo Nordisk Foundation, the Novo Nordisk Board and Lars Fruergaard Jørgensen have jointly concluded that ...
Obesity drug maker Novo Nordisk ousts CEO as competition weighs
Novo Nordisk CEO Lars Fruergaard Jorgensen will step down amidst growing concerns about the company's competitive position in ...
BioSpace2h
Novo Nordisk CEO Jørgensen to Depart With Danish Pharma’s Shares in Freefall
Over his eight years as CEO, Novo’s sales, profits and share price have almost tripled, the company said. However, the shares ...
Fierce Biotech2d
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Novo Nordisk is making yet another bet on obesity, offering Septerna more than $200 million in upfront and near-term payments ...